[go: up one dir, main page]

HUP9904642A2 - LH-RH-antagonisták alkalmazása diagnosztikai készítményként - Google Patents

LH-RH-antagonisták alkalmazása diagnosztikai készítményként

Info

Publication number
HUP9904642A2
HUP9904642A2 HU9904642A HUP9904642A HUP9904642A2 HU P9904642 A2 HUP9904642 A2 HU P9904642A2 HU 9904642 A HU9904642 A HU 9904642A HU P9904642 A HUP9904642 A HU P9904642A HU P9904642 A2 HUP9904642 A2 HU P9904642A2
Authority
HU
Hungary
Prior art keywords
hysteroscopy
diagnostic agent
antagonists
agent
cetre
Prior art date
Application number
HU9904642A
Other languages
English (en)
Inventor
Klaus Diedrich
Jürgen Engel
Ricardo Felberbaum
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of HUP9904642A2 publication Critical patent/HUP9904642A2/hu
Publication of HUP9904642A3 publication Critical patent/HUP9904642A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát diagnősztikai szer képezi a hysterőszkópiajavítására, amely egy LH-RH antagőnistát, különösen cetrőrelixettartalmaz. A szert a hysterőszkópia előtt és/vagy őperáció-előkészítésre használják. A szer alkalmazható tővábbáhysterőszkópiánál, az űterűs betegségi állapőtainak mint myőmának ésendőmetriűm-hyperpláziának ezt követő kezelésével kőmbinálva. ŕ
HU9904642A 1996-10-30 1997-10-23 Use of lh-rh antagonists as diagnostic agent HUP9904642A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19644994A DE19644994A1 (de) 1996-10-30 1996-10-30 Diagnostisches Mittel
PCT/DE1997/002456 WO1998018482A1 (de) 1996-10-30 1997-10-23 Verwendung von lh-rh antagonisten als diagnostisches mittel

Publications (2)

Publication Number Publication Date
HUP9904642A2 true HUP9904642A2 (hu) 2000-06-28
HUP9904642A3 HUP9904642A3 (en) 2000-07-28

Family

ID=7810344

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904642A HUP9904642A3 (en) 1996-10-30 1997-10-23 Use of lh-rh antagonists as diagnostic agent

Country Status (21)

Country Link
US (1) US6106805A (hu)
EP (1) EP0938330B1 (hu)
JP (1) JP2001502702A (hu)
AR (1) AR008516A1 (hu)
AT (1) ATE212856T1 (hu)
AU (1) AU717538B2 (hu)
BR (1) BR9712456A (hu)
CA (1) CA2219641C (hu)
DE (2) DE19644994A1 (hu)
DK (1) DK0938330T3 (hu)
ES (1) ES2172818T3 (hu)
HU (1) HUP9904642A3 (hu)
IL (1) IL129293A (hu)
NO (1) NO323690B1 (hu)
NZ (1) NZ335065A (hu)
PL (1) PL188998B1 (hu)
PT (1) PT938330E (hu)
RU (1) RU2193414C2 (hu)
TW (1) TW534817B (hu)
WO (1) WO1998018482A1 (hu)
ZA (1) ZA979693B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5574011A (en) * 1995-04-04 1996-11-12 Tien; Henry C. Compositions and methods for the treatment of male-pattern baldness

Also Published As

Publication number Publication date
BR9712456A (pt) 1999-10-19
WO1998018482A1 (de) 1998-05-07
CA2219641C (en) 2008-12-23
ATE212856T1 (de) 2002-02-15
HUP9904642A3 (en) 2000-07-28
PL188998B1 (pl) 2005-05-31
NZ335065A (en) 2000-06-23
PT938330E (pt) 2002-07-31
TW534817B (en) 2003-06-01
NO323690B1 (no) 2007-06-25
AU717538B2 (en) 2000-03-30
ZA979693B (en) 1998-05-07
DK0938330T3 (da) 2002-05-27
IL129293A0 (en) 2000-02-17
AU5221798A (en) 1998-05-22
NO991920D0 (no) 1999-04-22
DE59706334D1 (de) 2002-03-21
CA2219641A1 (en) 1998-04-30
ES2172818T3 (es) 2002-10-01
EP0938330B1 (de) 2002-02-06
JP2001502702A (ja) 2001-02-27
AR008516A1 (es) 2000-01-19
PL333174A1 (en) 1999-11-22
DE19644994A1 (de) 1998-05-07
IL129293A (en) 2005-12-18
EP0938330A1 (de) 1999-09-01
US6106805A (en) 2000-08-22
NO991920L (no) 1999-04-22
RU2193414C2 (ru) 2002-11-27

Similar Documents

Publication Publication Date Title
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
CA2259148A1 (en) Solid oral dosage forms of valsartan
ZA991408B (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
EA200200208A1 (ru) Синергитическая композиция
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
SE9503143D0 (sv) New preparation
HUP9901586A2 (hu) Antifungális szert és acetátpuffert tartalmazó készítmények és alkalmazásuk
BG105857A (en) Pregelatinized starch in a controlled release formulation
HUP9903732A2 (hu) cGMP-szintjét növelő szerek alkalmazása a jóindulatú prosztatatúltengés kezelésére szolgáló gyógyszerkészítmények előállítására
NZ506188A (en) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
EP0966966A3 (en) Nefazodone dosage form
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
WO2003011117A3 (en) Methods and compositions for treating and preventing distal bowel lesions
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
SE9902935D0 (sv) Pharmaceutical compositions
HUP9904642A2 (hu) LH-RH-antagonisták alkalmazása diagnosztikai készítményként
HUP0202324A2 (hu) Prukaloprid orális oldat
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
WO2001045685A3 (en) Formulations of adenosine a1 agonists
RU94000719A (ru) Алкилбензолы, композиции, содержащие алкилбензолы для визуализации желудочно-кишечного тракта, способ исследования желудочно-кишечного тракта
NO943070L (no) Antitussiva
PT1007052E (pt) Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
CA2381354A1 (fr) Use of cyamemazine for cold turkey benzodiazepine treatment
HUP9904327A2 (hu) Kinupristint és dalfopristint tartalmazó gyógyszerkészítmények és eljárás előállításukra

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ZENTARIS GMBH, DE

Free format text: FORMER OWNER(S): ASTA MEDICA AKTIENGESELLSCHAFT, DE; ZENTARIS AG, DE; ZENTARIS GMBH, DE